Clinical Practice Guideline for the Management of Communication and Swallowing in Children Diagnosed with Childhood Brain Tumour or Leukaemia

The guideline recommendations were approved by the Chief Executive Officer of the National Health and Medical Research Council on 23 November, 2020 under section 14A of the National Health and Medical Research Council Act 1992.

In approving the guideline recommendations, National Health and Medical Research Council (NHMRC) considers that they meet the NHMRC standard for clinical practice guidelines. This approval is valid for a period of five years.

NHMRC is satisfied that the guideline recommendations are systematically derived, based on the identification and synthesis of the best available scientific evidence, and developed for health professionals practising in an Australian health care setting.

This publication reflects the views of the authors and not necessarily the views of the Australian Government.

Guideline developer:

The University of Sydney, NeuroKids Research Laboratory

Cite this guideline

Childhood Brain Tumour or Leukaemia (CBTL) Guideline Working Party. Clinical Practice Guideline for the Management of Communication and Swallowing in Children Diagnosed with Childhood Brain Tumour or Leukaemia. Sydney: The University of Sydney, NeuroKids Research Laboratory. [Version URL: https://wiki.cancer.org.au/australiawiki/index.php?oldid=215289, cited 2023 May 28]. Available from: https://wiki.cancer.org.au/australia/Guidelines:Childhood_Brain_Tumour_Leukaemia.

Publication date
December 2020, Recommended Update: 2025

Contact
Dr Kimberley Docking, The University of Sydney, Faculty of Medicine and Health, Sydney School of Health Sciences
Email: kimberley.docking(at)sydney.edu.au